---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-027349"
form_type: "8-K"
ticker: null
cik: "0001850838"
company_name: "Omega Therapeutics, Inc."
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:37:17.835575+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Omega Therapeutics files for Chapter 11 bankruptcy with $9.8M DIP financing

## Summary
- Filed voluntary Chapter 11 petition on February 10, 2025 in Delaware Bankruptcy Court.
- Received interim approval for $9,820,908 DIP facility from Flagship affiliate; $3,931,953 funded Feb 13.
- DIP includes roll-up of $1,475,178 prepetition note plus $165,000 fees; 10% interest, matures 70 days post-petition.
- Court-approved milestones: final DIP order by day 30; asset sale order by day 60; closing by day 70.
- Company remains debtor-in-possession; Flagship entities are significant stockholders.

## SEC filing metadata
- accession: 0001193125-25-027349
- form_type: 8-K
- cik: 0001850838
- company_name: Omega Therapeutics, Inc.
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 1.03, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850838/000119312525027349/0001193125-25-027349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850838/000119312525027349/d896578d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-027349
- JSON: https://secwatch.observer/filing/0001193125-25-027349.json
- Plain text: https://secwatch.observer/filing/0001193125-25-027349.txt

## Key facts
- Distress & Bankruptcy
  Omega Therapeutics, Inc. entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2025-02-10).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2025-02-10
  source text: On February 10, 2025 (the “Petition Date”), Omega Therapeutics, Inc. (the “Company” or “Debtor”) commenced a chapter 11 case (the “Chapter 11 Case”) as debtor in possession in a voluntary proceeding under Chapter 11 of the United States Code
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850838/000119312525027349/0001193125-25-027349-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.